National Health (Commonwealth Price - Pharmaceutical benefits supplied by private hospitals) Determination 2020 (PB 99 of 2020)
3Definitions
Start here
Get a plain-English read of 3
Turn the raw legal text into a practical explanation grounded in National Health (Commonwealth Price - Pharmaceutical benefits supplied by private hospitals) Determination 2020 (PB 99 of 2020).
3 Definitions
In this instrument:
Act means the National Health Act 1953.
approved ex‑manufacturer price has the same meaning as in subsection 84(1) of the Act.
approved hospital authority means a hospital authority that has been approved by the Minister under subsection 94(1) of the Act.
Approved Pharmacists Determination means the Commonwealth price (Pharmaceutical benefits supplied by approved pharmacists) Determination 2020 (PB 66 of 2020).
brand has the same meaning as in Part VII of the Act.
current figure has the same meaning as in section 99G of the Act.
dangerous drug means:
(a) a pharmaceutical benefit mentioned in Schedule 3 to the National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Determination 2019 (PB 114 of 2019); or
(b) a pharmaceutical benefit that, under the law of a State or Territory, is classified as a dangerous drug.
dangerous drug fee has the same meaning as in Approved Pharmacists Determination.
determined quantity, of a listed brand of a pharmaceutical item, has the same meaning as in Part VII of the Act.
dispensed price:
(a) for a ready‑prepared pharmaceutical benefit—has the meaning given by section 9; and
(b) for an extemporaneously‑prepared pharmaceutical benefit—has the meaning given by subsection 16(1).
extemporaneously‑prepared dispensing fee has the same meaning as in the Approved Pharmacists Determination.
extemporaneously‑prepared pharmaceutical benefit means a pharmaceutical benefit that is not a ready‑prepared pharmaceutical benefit.
listed brand has the same meaning as in Part VII of the Act.
maximum quantity, of a brand of a pharmaceutical item, means a quantity or number of units of the pharmaceutical item determined under paragraph 85A(2)(a) of the Act in relation to that brand of pharmaceutical item.
pack quantity has the same meaning as in subsection 84(1) of the Act.
Note: The Minister may determine one or more pack quantities for a brand of a pharmaceutical item under subsection 84AK(2) of the Act. The quantities determined are the quantities in manufacturer’s PBS packs.